Kieran Mudryy

Following discussions between ARIPO and the China National Intellectual Property Administration (CNIPA), ARIPO has implemented a bilateral Patent Prosecution Highway (PPH) pilot program in partnership with CNIPA.  The program enables an applicant who has received a positive outcome on patent claims from one participating office to request expedited examination of corresponding claims in another participating office. This allows the applicant to obtain a patentability decision in the second office more quickly. https://lnkd.in/dyA-RMxM

4

Fascinating, fascinating case! Beijing IP Court REVERSES the Chinese patent office's invalidation of Novo Nordisk's semaglutide (Ozempic®, Wegovy®) patent, upholding the validity of the patent for this blockbuster drug. Even more interesting? It's because of post filing supplemental data that Novo Nordisk submitted. Any patent attorney who has experience prosecuting biopharma patents in China will agree that China's strict stance on accepting post-filing supplemental data has always been a sore spot. This decision analyzes and really teases apart the reasons why certain post-filing data (submitted by Novo Nordisk) were acceptable, while others were not. The nuanced differences are quite subtle, and it's worth reading the whole article to understand (and apply) it. I gave a talk about this case at #LSPN2024 in #Boston earlier this year. I'm glad I finally found the time to write up the article (together with the help of my colleagues Yolanda Wang and Audrey Cheung). Enjoy! https://lnkd.in/gScYh9kg #semaglutide #ozempic #wegovy #chinapatentlaw #chinapatentstrategy #patentattorney #patentlaw #intellectualproperty #pharmaceuticals #generics #innovators #novonordisk #obesity #cnipa #beijingipcourt

31

2 Comments

It’s that time of the year when we indulge in some shameless self-promotion! We are extremely grateful about the latest review from Intellectual Asset Magazine in the new IAM 1000 rankings and send profound thanks to our clients for those words (and their continued trust) and to IAM. Our firm is ranked in the “Silver” Tier for patent prosecution in Singapore, and our attorneys Michael McLaughlin and Blayne Peacock are ranked as “Recommended” or higher.   IAM wrote:   ‘Plaudits come thick and fast for patent prosecution powerhouse McLaughlin IP: “Without question, McLaughlin IP is the premier IP boutique in Singapore.” “Its service is distinguished by professionalism and quality, but the most important thing for us is that they are really ready to dialogue with the client, ready to study those aspects that are important to the client and build their recommendations in accordance with this. We understand that our inventions can seem daunting and our wishes can seem odd, and we greatly value the friendliness and professionalism that McLaughlin IP employees show.” Prioritising quality over quantity is the outfit’s model for success. It provides some of the most tailored and customised services to its discerning patrons, including the likes of Alibaba Group, Visa, MUFG Bank, Boehringer Ingelheim International and Amgen. Leading the charge is eponymous founder Michael McLaughlin. An electrical ace who previously practised as an electrical design engineer, he can quickly parse almost any engineering invention. Next to him is Blayne Peacock, who attracts effusive praise from patrons regarding his excellence: “Blayne has an equally deep knowledge of both IT and patent law. I had to work a lot with different lawyers in different countries, and most often I needed to explain to the lawyer what exactly the difference was. But due to his brilliant command of technical knowledge, this was not required in our joint work. It was enough for me to just point out the differences, and Blayne immediately proposed an amendment to the claims – absolutely correct from a technical point of view! Working on IT inventions with him is a real pleasure.”’ https://lnkd.in/gs7Knctd. 

4

In case you missed the live event, catch up on the current intellectual property situation in the Power GaN field with Dr. Rémi Comyn. 👉 Webinar - Current and emerging trends in the power GaN patent landscape https://lnkd.in/dR3QgJHF #patent #innovation #webinar #powerGaN #semiconductor

4

In our latest article, our esteemed collaborator, Justas Širmenis from METIDA, breaks down the intricacies of patent registration in Lithuania. Navigating the patent registration process is vital in #Lithuania’s thriving innovation landscape. At METIDA experts excel in ensuring your #patents are registered effectively to safeguard and enhance their value. Have an #IP to protect? Utilize our #AI Assistant to register your patent in Lithuania - https://lnkd.in/gZPBgaB9 Why File a Patent in Lithuania? 1) Protect Your Innovations: Secure your intellectual property rights from the start. 2) Increase Market Presence: A strong patent portfolio attracts partners and investors. Expert Support: With the complexities of IP management, the seasoned team at METIDA ensures seamless compliance with all legal and procedural requirements. Need assistance with patent registration in Lithuania? Contact METIDA via IPNOTE now to get started - https://lnkd.in/gu7rN_NG.. Discover more about securing your innovations with METIDA on the iPNOTE platform. Ready to protect your creativity? Register patent in Lithuania with our AI Assistant - https://lnkd.in/gfnkQCFB.. #IntellectualProperty

80

10 Comments

🎙 Nucleate Singapore Pulse 👨‍🔬 This month, Nucleate was thrilled to interview Dr. Adam Gregory, a patent attorney at Mewburn Ellis specializing in life sciences. Dr. Gregory delves into the world of patenting strategies, IP protection, and the intricate balance between scientific innovation and legal safeguards. In this insightful episode, Dr. Adam Gregory emphasizes the importance of early engagement with patent attorneys to strategize intellectual property protection. He highlights key pitfalls such as weak initial patent filings and premature public disclosures, underscoring the crucial role of timing and strategy in securing robust patents. Dr. Gregory also illustrates how an effective patent strategy has significantly driven the growth and success of Singapore biotech companies. Listen and follow us on Spotify 👉https://lnkd.in/gbjFR69f and Apple Podcasts 👉https://lnkd.in/g_Kt_ahq Show notes and transcripts 👉 https://lnkd.in/gaT8WHAg Podcast team: John Joson Ng and Jessie Wong Ling Ai Nucleate team: Liyana Ayub Ow Yong Kim Whye Leong Jiang Yeow Ignacius Tay Samantha Wong Ivan Seah, MBBS/MBA/MPH Ying Tong Yeo Shruti Sridhar Gloria Chan Isha Karnik #NucleateSingapore #Podcast #LifeSciences #Innovation #IntellectualProperty #PatentStrategy

21

Deep tech innovations are transforming industries but often struggle to secure funding due to misconceptions and knowledge gaps. Our PIPI (Perpetual IP Income) model addresses these challenges by structuring funding around milestones, reducing perceived risks, and fostering transparency. By bridging the knowledge gap and debunking myths, we can unlock the full potential of deep tech for groundbreaking advancements. https://lnkd.in/g_AF5zAu #DeepTech #VC #IP #Patents

3